Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01134029 · ClinicalTrials.gov registry record · NA

Planned CORR: Planned Care for Obesity and Risk Reduction

A NA study, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
262
Enrollment target

NCT01134029: Completed NA study, sponsored by University of California, San Diego.

NCT01134029 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 262 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01134029, a NA study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
262 participants
Enrollment target

Study Summary

The researchers propose a randomized controlled trial to evaluate how well an intervention, Planned Care for Obesity \& Risk Reduction (Planned CORR), supports primary care treatment of obesity in adults with at least one cardiovascular risk factor (CVRF).

Interventions

  • BEHAVIORAL Stepped Care

Trial Details

FieldValue
Enrollment Target 262 participants
Start Date 2009-11
Est. Completion 2013-10
Phase NA
University of California, San Diego

775 total trials

What the finished NCT01134029 record still lists

NCT01134029 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Stepped Care is the first listed.

NCT01134029 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01134029 about?

NCT01134029 is a clinical study titled "Planned CORR: Planned Care for Obesity and Risk Reduction". The researchers propose a randomized controlled trial to evaluate how well an intervention, Planned Care for Obesity \& Risk Reduction (Planned CORR), supports primary care treatment of obesity in adults with at least one cardiovascular risk factor (CVRF).

What is the current status of trial NCT01134029?

This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2009-11. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01134029?

The interventions under investigation include: Stepped Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01134029?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01134029's enrollment target sits among peer trials

262 397th of 2000 higher than 1,604 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03713268 · 262 participants

    Intraoperative OCT Guidance of Intraocular Surgery II

  • NCT06074380 · 262 participants · Phase 4

    Non Inferiority Trial Investigating Surfactants Administered Via MIST

  • NCT06293703 · 262 participants · NA

    Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)

  • NCT06780137 · 262 participants · Phase 1

    A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01134029, the US trial registry maintained by the National Library of Medicine. NCT01134029 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.